Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

APLS

Apellis Pharmaceuticals Inc

May 13 • 04:00PM ET

41.03

0.00 0.00 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: RYTM VKTX CORT KRYS IDYA

| Held by: XBI VTI VB VBK VXF SPSM SLYG SCHA VIOO DFMC

Scroll to Statements

Index	-	P/E	41.01	EPS (ttm)	1.00	Insider Own	30.77%	Shs Outstand	127.92M	Perf Week	-0.22%
Market Cap	5.25B	Forward P/E	-	EPS next Y	-0.07	Insider Trans	-0.33%	Shs Float	88.63M	Perf Month	0.44%
Enterprise Value	5.32B	PEG	-	EPS next Q	-0.28	Inst Own	86.29%	Short Float	12.13%	Perf Quarter	83.91%
Income	133.27M	P/S	4.75	EPS this Y	-613.79%	Inst Trans	-9.43%	Short Ratio	1.68	Perf Half Y	115.95%
Sales	1.11B	P/B	12.65	EPS next Y	93.06%	ROA	14.10%	Short Interest	10.75M	Perf YTD	63.34%
Book/sh	3.24	P/C	12.91	EPS next 5Y	84.89%	ROE	46.02%	52W High	41.14 -0.27%	Perf Year	137.44%
Cash/sh	3.18	P/FCF	140.18	EPS past 3/5Y	- -	ROIC	16.87%	52W Low	16.10 154.84%	Perf 3Y	-53.35%
Dividend Est.	-	EV/EBITDA	31.94	Sales past 3/5Y	136.98% 31.98%	Gross Margin	90.09%	Volatility	0.13% 0.15%	Perf 5Y	-10.10%
Dividend TTM	-	EV/Sales	4.81	EPS Y/Y TTM	158.69%	Oper. Margin	14.95%	ATR (14)	0.33	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.16	Sales Y/Y TTM	42.46%	Profit Margin	12.06%	RSI (14)	84.48	Recom	2.90
Dividend Gr. 3/5Y	- -	Current Ratio	3.63	EPS Q/Q	119.32%	SMA20	0.14%	Beta	-0.25	Target Price	41.19
Payout	0.00%	Debt/Eq	1.15	Sales Q/Q	60.85%	SMA50	26.80%	Rel Volume	0.00	Prev Close	41.03
Employees	739	LT Debt/Eq	0.90	Earnings	Feb 24 BMO	SMA200	58.68%	Avg Volume	6.42M	Price	41.03
IPO	Nov 09, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	-25.67% 0.26%	Trades		Volume	0	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)